Real-world use of sunitinib in Japanese patients with advanced renal cell carcinoma: efficacy, safety and biomarker analyses in 1689 consecutive patients

OBJECTIVE: This prospective, post-marketing study collected sunitinib safety and efficacy data in Japanese patients with unresectable/metastatic renal cell carcinoma. Retrospective analysis investigated adverse events as potential sunitinib efficacy biomarkers. METHODS: Patients administered sunitin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Jpn J Clin Oncol
Main Authors: Akaza, Hideyuki, Naito, Seiji, Ueno, Naomi, Aoki, Kouji, Houzawa, Hiroyuki, Pitman Lowenthal, Susan, Lee, Sang-Yoon
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2015
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4461239/
https://ncbi.nlm.nih.gov/pubmed/25917359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyv045
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares